Abstract
Introduction:
The Biological Sample Management Platform (PGEB) of the Centre Léon Bérard is responsible for the preparation, preservation, storage, and provision of the institution’s sample collection. The PGEB was approached to integrate a neuroblastoma collection, one of the most common pediatric cancers. This collection was initiated through the diagnostic reference activity for neuroblastoma at the Centre Léon Bérard.
Objectives:
To requalify pediatric biological samples collected between 1984 and 2024 and to make them available for pediatric research protocols.
Methods:
This study began with an assessment of the data associated with each of the 21,389 samples in the collection. These data were then compared with relevant regulations and consensus documents related to biobank data management, as well as the minimum data requirements for research use. Based on this, a methodology for sorting samples—either for retention or disposal—was applied.
Results:
A set of minimum information criteria was established to revalue the samples. Various texts applicable in France mention the minimum data required for making samples available, but no consensus exists, either nationally or internationally. Furthermore, 65% of the samples met the criteria and were retained for future research use.
Conclusions:
This article describes the research work that led to the identification of minimum required data. However, further development is needed to harmonize practices regarding data management and interoperability.
Keywords
Get full access to this article
View all access options for this article.